Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02200133 · ClinicalTrials.gov registry record · NA
Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors
A NA study, sponsored by Center for International Blood and Marrow Transplant Research.
- Completed
- Registry status
- NA
- Development phase
- 495
- Enrollment target
NCT02200133 is a NA study that has completed, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 495 participants.
The verdict
NCT02200133, a NA study, has completed, sponsored by Center for International Blood and Marrow Transplant Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 495 participants
- Enrollment target
Study Summary
This randomized study will compare a personalized Survivorship Care Plan (SCP) template with usual care (no SCP). The investigators hypothesize that the personalized SCP that incorporates patient specific treatment exposures and provides a framework for long term followup based on those exposures and subsequent risks for late complications will enhance patient survivorship confidence in knowledge, increase adherence to recommended healthcare, improve health behaviors and reduce HCT-related emotional distress.
Interventions
- OTHER Individualized Survivorship Care Plan (SCP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 495 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02200133
The ClinicalTrials.gov registry entry for NCT02200133 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 495 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for International Blood and Marrow Transplant Research, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Individualized Survivorship Care Plan (SCP) is the first listed.
NCT02200133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02200133 about?
NCT02200133 is a clinical study titled "Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors". This randomized study will compare a personalized Survivorship Care Plan (SCP) template with usual care (no SCP). The investigators hypothesize that the personalized SCP that incorporates patient specific treatment exposures and provides a framework for long term followup based on those exposures an...
What is the current status of trial NCT02200133?
This trial is currently completed. It is a NA study. The enrollment target is 495 participants. The study started on 2015-04. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02200133?
The interventions under investigation include: Individualized Survivorship Care Plan (SCP) (OTHER).
Who is sponsoring clinical trial NCT02200133?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.